• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication for adhd and anxiety in adults during pregnancy and breastfeeding is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these drugs can affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological conditions like impaired vision or hearing seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the advantages of using them against the risks to the fetus. Doctors don't have the data needed to provide clear recommendations however they can provide information on the risks and benefits to assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who took ADHD medications during early pregnancy did not have a significantly increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a vast population-based study of case-control to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy and those who had not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to make sure that the classification was accurate and to eliminate any bias.

The study conducted by the researchers was not without its limitations. In particular, they were unable to distinguish the effects of the medication from those of the disorder that is underlying. This makes it difficult for researchers to determine if the few associations observed between the groups exposed were due to the use of medications or caused by the presence of comorbidities. Additionally, the researchers did not study the long-term outcomes of offspring.

The study showed that infants whose mother took ADHD medication during pregnancy had a higher chance of being admitted to the neonatal care unit (NICU), compared to those whose mothers didn't take any medication during pregnancy or stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who were taking stimulant buy adhd medication uk medication during pregnancy were also at an increased chance of having a caesarean section or having a baby born with an low Apgar score (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications during early pregnancy could be offset by the greater benefit for both mother and child of continuing treatment for the woman's disorder. Doctors should discuss with their patients about this and, if possible, help them develop coping strategies that could reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to maintain treatment or stop as more women are diagnosed with ADHD. These decisions are often made without clear and reliable evidence. Instead, doctors must consider their own expertise in conjunction with the experiences of other doctors, and the research that has been conducted on the subject.

The issue of potential risks to the infant can be difficult to determine. The research on this subject is based on observations rather than controlled studies, and the results are conflicting. Most studies limit their analysis to live births, which can underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study that is discussed in this journal club addresses these issues by examining data on both live and deceased births.

The conclusion is that while some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link, and most studies have a neutral or slightly negative impact. Therefore, a careful risk/benefit assessment must be done in each situation.

For women suffering from ADHD and ADD, the decision to stop taking medication is difficult if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of loneliness. Additionally, the loss of medication can interfere with the ability to perform work-related tasks and safely drive, which are important aspects of a normal life for many people suffering from ADHD.

She suggests that women who are not sure whether to continue taking medication or stop due to pregnancy, educate their family members, coworkers, and acquaintances about the condition, the effects on daily functioning, and the advantages of staying on the current treatment. In addition, educating them can aid in ensuring that the woman feels supported when she is struggling with her decision. Some medications can pass through the placenta. If a woman decides to not take her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her infant.

Birth Defects and Risk of

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns over the impact that these drugs could have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Researchers utilized two massive datasets to analyze more than 4.3 million pregnancies and determine if stimulant medication use increased the risk of birth defects. Although the risk overall remains low, the scientists discovered that the first-trimester exposure to ADHD medications was linked to an increase in the risk of certain heart defects such as ventriculoseptal defect (VSD).

The researchers behind the study found no connection between the use of early medications and other congenital anomalies, like facial clefting, or club foot. The results are in agreement with previous studies which showed the existence of a slight, but significant increase in cardiac malformations for women who began taking ADHD medication prior to the time of pregnancy. The risk grew in the later part of pregnancy, when a lot of women are forced to stop taking their ADHD medication.

Women who took ADHD medications in the first trimester of their pregnancies were also more likely to experience caesarean sections, a low Apgar score following delivery, and a baby that required breathing assistance during birth. However, the authors of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have any other medical conditions that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they see pregnant women. They advise that while the discussion of the benefits and risks is important however, the decision to stop or continue medication should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also warn that while discontinuing the medications is an alternative, it is not an option that is recommended due to the high rate of depression and other mental health issues for women who are expecting or who are recently post-partum. Further, the research suggests that women who decide to stop taking their medication are more likely to experience a difficult time getting used to life without them after the birth of their baby.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women with adhd medication pregnancy - next page - may face a lot of challenges when they have to manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to a new routine. Many women opt to continue taking their ADHD medication during pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medication passes through breast milk in low amounts. However, the frequency of exposure to medication by the newborn may differ based on the dosage, frequency it is administered and the time of the day the medication is administered. Additionally, different drugs enter the infant's system via the gastrointestinal tract or through breast milk. The effect on the health of a newborn is not fully comprehended.

Due to the absence of research, some physicians may recommend stopping stimulant drugs during the pregnancy of a woman. This is a difficult decision for the patient, who must balance the benefits of continuing her medication against the potential risks to the fetus. Until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal period.

Numerous studies have proven that women can continue taking their ADHD medication safely during pregnancy and breast-feeding. In response, a growing number of patients are opting to continue their medication. They have concluded through consultation with their doctors that the benefits of continuing their current medication outweigh any potential risks.

Women who suffer from buy adhd medication online uk who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons of continuing treatment. This includes non prescription adhd medication for adults-pharmacological strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD be aware of their symptoms and the underlying disorder, learn about available treatment options and strengthen existing strategies for coping. This should be a multidisciplinary approach with the GP, obstetricians and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, and monitoring for indicators of deterioration, and, if necessary, adjustments to the medication regimen.